fda glp-1 compounding warning october 2025 Beyond the Headlines: Letters to Compounders Dr. Elizabeth Kazarian, MD |

Description

(Bifidobacterium lactis BS01, Bifidobacterium breve BR03, Lactobacillus acidophilus LA02, Lactobacillus plantarum LP09, Lactobacillus rhamnosus LR06, Lactobacillus casei LC03, Bifidobacterium bifidum BB01, Streptococcus thermophilus YO8, Lactobacillus plantarum LP01, Lactobacillus rhamnosus LR05, Lactobacillus rhamnosus GG, Bifidobacterium longum BL03, Lactobacillus reuteri LRE02, Lactobacillus salivarius subsp. salivarius CRL1328, Bifidobacterium lactis BA05)

And just as importantly, what should patients do when their progress suddenly stalls, even while still on the medication?

Here are 4 questions to ask your doctor and set yourself up for long-term weight loss results!

Energy dips are common during the first weeks of semaglutide treatment, but fatigue typically improves as your body adjusts

GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound arent just changing waistlines they're reshaping healthcare and creating a universe of opportunities for visionary investors.